Counterpoint: Should an attempt be made to withdraw inhaled corticosteroids in all patients with stable GOLD 3 (30% ≤ FEV1 < 50% predicted) COPD? No.

Inhaled corticosteroids (ICS) have been accepted by successive GOLD documents as being effective agents for the prevention of COPD exacerbations and decline in health status. The combination of an ICS and a long-acting beta-agonist (LABA) is superior to the LABA alone in achieving these positive ben...

詳細記述

書誌詳細
第一著者: Pavord, I
フォーマット: Journal article
言語:English
出版事項: Elsevier 2018

類似資料